ZA200109989B - Pharmaceutical composition containing sibutramine and orlistat. - Google Patents

Pharmaceutical composition containing sibutramine and orlistat.

Info

Publication number
ZA200109989B
ZA200109989B ZA200109989A ZA200109989A ZA200109989B ZA 200109989 B ZA200109989 B ZA 200109989B ZA 200109989 A ZA200109989 A ZA 200109989A ZA 200109989 A ZA200109989 A ZA 200109989A ZA 200109989 B ZA200109989 B ZA 200109989B
Authority
ZA
South Africa
Prior art keywords
orlistat
pharmaceutical composition
composition containing
containing sibutramine
sibutramine
Prior art date
Application number
ZA200109989A
Inventor
Heal David John
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA200109989B publication Critical patent/ZA200109989B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200109989A 1999-06-24 2001-12-05 Pharmaceutical composition containing sibutramine and orlistat. ZA200109989B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914744.9A GB9914744D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA200109989B true ZA200109989B (en) 2003-02-26

Family

ID=10855955

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109989A ZA200109989B (en) 1999-06-24 2001-12-05 Pharmaceutical composition containing sibutramine and orlistat.

Country Status (21)

Country Link
EP (1) EP1187606A1 (en)
JP (1) JP2003503349A (en)
KR (1) KR20020015357A (en)
CN (1) CN1358092A (en)
AU (1) AU5533200A (en)
BG (1) BG106180A (en)
BR (1) BR0011880A (en)
CA (1) CA2375972A1 (en)
CZ (1) CZ20014613A3 (en)
GB (1) GB9914744D0 (en)
HK (1) HK1049278A1 (en)
HU (1) HUP0201878A3 (en)
IL (1) IL147079A0 (en)
MX (1) MXPA01012936A (en)
NO (1) NO20016224L (en)
PL (1) PL352402A1 (en)
RU (1) RU2229289C2 (en)
SK (1) SK18242001A3 (en)
TR (1) TR200103699T2 (en)
WO (1) WO2001000205A1 (en)
ZA (1) ZA200109989B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696495B2 (en) * 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
CA2585175A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
JP2010503709A (en) * 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド Synthesis, methods of use and compositions of cycloalkylmethylamines
BRPI0716002A2 (en) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd Inclusion complex, process of preparation of an inclusion complex and composition of treatment and prevention of hypochondria and obesity
CN101890017A (en) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 Medicament composition containing sibutramine and stanin fat-reducing medicament and application thereof
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
MX336980B (en) * 2010-12-21 2016-02-09 Senosiain S A De C V Lab Combination and composition for treating obesity.
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727131D0 (en) * 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
PL352402A1 (en) 2003-08-25
HUP0201878A3 (en) 2005-04-28
RU2229289C2 (en) 2004-05-27
CZ20014613A3 (en) 2003-04-16
NO20016224D0 (en) 2001-12-19
AU5533200A (en) 2001-01-31
BR0011880A (en) 2002-03-19
HK1049278A1 (en) 2003-05-09
NO20016224L (en) 2002-02-12
TR200103699T2 (en) 2002-04-22
IL147079A0 (en) 2002-08-14
MXPA01012936A (en) 2004-04-21
GB9914744D0 (en) 1999-08-25
SK18242001A3 (en) 2003-02-04
WO2001000205A1 (en) 2001-01-04
EP1187606A1 (en) 2002-03-20
JP2003503349A (en) 2003-01-28
BG106180A (en) 2002-08-30
KR20020015357A (en) 2002-02-27
CN1358092A (en) 2002-07-10
HUP0201878A2 (en) 2003-08-28
CA2375972A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
ZA993338B (en) Pharmaceutical formulations.
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
HK1045650A1 (en) Pharmaceutical composition.
MXPA02000992A (en) Microarrays and their manufacture.
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HK1042845A1 (en) Cosmetic composition.
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
ZA200104280B (en) Pharmaceutical combination preparations.
ZA200005510B (en) Pharmaceutical composition.
ZA200000857B (en) Pharmaceutical composition.
IL152978A0 (en) Macromolecular drug complexes and compositions containing the same
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
EP1210084A4 (en) Pyridomorphinans, thienomoprhinans and use thereof
ZA200109989B (en) Pharmaceutical composition containing sibutramine and orlistat.
ZA987392B (en) Pharmaceutical composition.
HK1040488A1 (en) Pharmaceutical formulations.
ZA200006020B (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
HK1052168A1 (en) N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them.
HK1044117A1 (en) Pharmaceutical composition.
HUP0103006A3 (en) Substituted betha-diketones, pharmaceutical compositions containing them and their use
ZA994697B (en) Pharmaceutical formulation.